Research Projects & Grants

Federal

  • COG AALL1631: International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones, Role: Investigator, Children Oncology Group, (07/2024 - 07/2025) Status: Approved
  • COG ACNS1422: A Phase 2 Study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients, Role: Investigator, Children Oncology Group, (06/2024 - 06/2025) Status: Approved

Internal

  • Radiation medicine research registry, Role: Investigator, LLU Dept. of Radiation Medicine, (10/2024 - 09/2025) Status: Approved
  • Proton radiotherapy for isolated lymph node recurrence in gynecological cancers, Role: Investigator, LLU Dept. of Radiation Medicine, (02/2021) Status: Approved
  • Phase II trial of partial breast proton therapy for early stage breast cancer with low and intermediate risk factors, Role: Investigator, LLU Dept. of Radiation Medicine, (08/2024 - 07/2025) Status: Approved
  • Phase II trial of lumpectomy and partial breast proton therapy for early stage breast cancer, Role: Investigator, LLU Dept. of Radiation Medicine, (06/2024 - 06/2025) Status: Approved